Press Releases

Viewing by tag: synthetic cannabinoids

  • New pipe ban will increase harm to cannabis consumers, and encourages users of legal synthetics to smoke more

    posted on the April 15th, 2014 by Chris

    The Government will increase harm by further restricting the sale, supply and importation of drug harm reduction equipment. “This National-led Government seems to be encouraging use of the more harmful synthetics over safer natural cannabis. Now it is increasing harm even more, by forcing them to smoke larger amounts,” said Chris Fowlie, spokesperson for the […]

  • NORML’s Position on ‘legal highs’ and the Psychoactive Substances Act

    posted on the March 26th, 2014 by Chris

    NORML supports the intention of the Psychoactive Substances Act It should be widened to cover all low-risk drugs including cannabis Legalising and regulating cannabis is the most effective way of closing down the market for synthetic cannabis The idea of legalising and regulating low risk drugs instead of trying to ban them is one that […]

  • Complete rethink needed of all drug laws

    posted on the March 1st, 2014 by norml

    NORML has advised the Ministry of Health a complete rethink is needed of all drug control laws and policies. In it’s submission to the discussion document on the New National Drug Policy, New Zealand’s longest running cannabis law reform group said the lack of any willingness to look at first principles, and the missed opportunity […]

  • Regulate natural cannabis to reduce synthetic cannabis

    posted on the May 29th, 2013 by norml

    Demand for synthetic cannabis would plummet if natural cannabis were legally and safely available here as in Colorado, where laws have today been enacted to ensure the world’s first legal marijuana market for adults will be a robust and comprehensive regulatory system. “Our parliament is grappling with regulations controlling the sale of synthetic cannabis and […]

  • Study: Synthetic Cannabinoids Produce Anti-Cancer Effects In Human Liver Cancer Cells

    posted on the October 12th, 2012 by Chris

    As the debate continues in New Zealand about regulating the availability of products containing synthetic cannabinoids, a new study has shown two particular compounds exhibit anti-cancer effects in human liver cancer cells. This report is from US NORML’s Paul Armentano. Thursday, 11 October 2012 Tehran, Iran: The administration of synthetic cannabinoid agonists reduce cell viability […]

  • Ban on Low Risk Drugs should be Temporary, says NORML

    posted on the August 2nd, 2011 by Phil

    Drug law reform organisation NORML says the government’s temporary ban on synthetic cannabis provides time for proper consideration of the Law Commission’s report issued in May. “Low risk drugs like cannabis and party pills should be regulated, not banned”, says Acting President Phil Saxby. “The huge popularity of party pills before they were banned is […]